Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep1163 | Thyroid cancer | ECE2016

Biphasic synovial sarcoma: an exceptional rare cervical mass

Ghemigian Adina , Carsote Mara , Petris Rodica , Dumitrascu Anda , Valea Ana , Terzea Dana , Paun Diana Loreta

Introduction: Synovial sarcoma represents a type of cancer derived from soft tissues; young males are more affected.Material and methods: This is a case report of a male with a cervical mass confirmed as sarcoma. Later on the investigations lead to the discovery of a thyroid nodule challenging the differential diagnosis. We assessed thyroid ultrasound, computed tomography (CT) at the cervical, thorax, mediastinum and abdomen; TSH (Thyroid Stimulating Hor...

ea0059ep70 | Neoplasia, cancer & late effects | SFEBES2018

MEN 2A – a rare syndrome with variable intrafamilial gene expressivity, case presentation

Hilma Ana Maria , Gogoi Adriana , Jercalau Simona , Dumitrascu Anda , Goldstein Andrei , Badiu Corin

MEN2A is an autosomal dominant inherited syndrome, caused by a gain of function germline mutation in the RET proto-oncogene, with multiglandular tumoral development. Although the presence of MTC is very high and 50% of patients present with pheochromocytoma, the penetrance of hyperparathyroidism is estimated to be between 9 and 34%. The clinical presentation of the syndrome varies widely even in members of the same family, because of the difference of gene penetration (1). In ...

ea0038p338 | Pituitary | SFEBES2015

Evolution in acromegalic patients with discordant GH–IGF1 levels during medical treatment

Gheorghiu Monica Livia , Vargatu Iulia , Trifanescu Raluca Alexandra , Dumitrascu Anda , Caragheorgheopol Andra

Acromegaly control/remission is defined by stringent criteria: normal age-/sex-adjusted IGF1 and random GH (GHr) <1 ng/ml or a GH nadir (GHn) during oral glucose tolerance test (OGTT) of <0.4 ng/ml. However discordances between GH and IGF1 have been recorded in about 30% of patients. We retrospectively analyzed the evolution in patients with acromegaly and discordant GH–IGF1 levels while being treated with somatostatin analogs (SSA) and/or cabergoline (CAB).<p...

ea0035p60 | Adrenal Medulla | ECE2014

Olygosimptomatic malignant pheochromocytoma treated with 131I-MIBG

Jercalau Simona , Gabur Alexandra , Hortopan Dan , Stefanescu Ana Maria , Dumitrascu Anda , Badiu Corin

Introduction: Pheochromocytomas are rarely malignant, defined by the presence of cathecholamine – producing metastases. Malignant pheochromocytoma responds poorly to chemotherapy and radiotherapy. 131I-MIBG therapy can be used to prolong survival, with minor side effects.Case: A 45-years old woman known with malignant pheochromocytoma, with a long medical history, first came to our clinic in July 2012. Her diagnosis was suspected in 1999 ...

ea0035p891 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Pituitary non-secreting micro-incidentalomas and endocrine dysfunctions: a retrospective analysis in 236 Romanian patients

Carsote Mara , Mihai Alexandra , Geleriu Andreea , Dumitrascu Anda , Hortopan Dan , Petris Rodica , Paun Diana , Poiana Catalina

Introduction: The pituitary non-secreting microadenomas (or incidentalomas) are frequently diagnosed over the last decades thanks to imagery scan progresses and access. The gonadal dysfunction, as well as other pituitary deficiency is related to common genetic backup (+/− other pituitary dysfunctions) or may be incidental.Aim: We analyzed the endocrine profile in pituitary incidentalomas (microadenomas).Material and method: A...

ea0035p892 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Pituitary incidentaloma: an age-related study in 266 Romanian patients

Poiana Catalina , Carsote Mara , Ene Cristina , Mihai Alexandra , Dumitrascu Anda , Dusceac Roxana , Niculescu Dan , Peretianu Dan

Introduction: The pituitary tumors which are considered pituitary incidentalomas are accidentally discovered at pituitary scan and they associate a lack of pituitary hyper-secretion. Opposite to what generally are considered for adrenal incidentalomas, the pituitary incidentalomas are more frequent with years of life.Aim: We analyzed the incidentaloma sizes related to decades of age.Material and method: This is a retrospective stud...

ea0070aep713 | Pituitary and Neuroendocrinology | ECE2020

Pregnancy and pituitary adenomas: A case series

Dumitriu Roxana , Dusceac Roxana , Florentina Burcea Iulia , Baciu Ionela , Capatina Cristina , Dumitrascu Anda , Poiana Catalina

Introduction: Pituitary tumours may interfere with fertility and pregnancy may be uncommon in these cases, but some patients can conceive spontaneous. Also in pregnancy, due to the physiologic changes of the pituitary gland, gradual volume increase and cellular hyperplasia that target hormonal secretion, the evaluation of the pituitary function is very complex.Clinical cases: We present 5 cases of female patients (24 – 35 years old) that were diagn...

ea0070ep24 | Adrenal and Cardiovascular Endocrinology | ECE2020

Case report: Heterochronous Conn’s syndrome and a possible Cushing syndrome developed from bilateral adrenal masses, 5 years apart

Morea Alexandru , Lambrinoc Diana , Dumitrascu Anda , Florina Baciu Ionela , Poiana Catalina

Background: Primary hyperaldosteronism or Conn’s syndrome is one of the adrenocortical causes of hypertension, alongside hyperdeoxycorticosteronism, apparent mineralocorticoid excess and Cushing syndrome. The two types of hypertension-inducing adrenocortical syndromes (Conn’s and Cushing) are extremely rare to be decribed in the same patient. We describe a case of a patient with clinical and biochemical evidence of Conn’s syndrome due to a left adrenal adenom...

ea0070ep54 | Adrenal and Cardiovascular Endocrinology | ECE2020

Cortisol and androgens secreting left adrenal carcinoma

Margarit Emma , Simona Andreea Găloiu , Dumitrascu Anda , Caragheorgheopol Andra , Beuran Mircea , Poiana Catalina

Introduction: Adrenal carcinomas are rare tumor. It has an estimated incidence of ~0.5–2 new cases per million people per year. Just 25% of adults with hormone-secreting adrenal carcinomas present overproduction of both glucocorticoids and androgens. Women develop adrenal carcinomas more often than men.Objectives: We report a case of 47-year-old female presented with weight gain, generalized weakness and hypertension for the last 6 months. Phy...

ea0070ep270 | Endocrine-related Cancer | ECE2020

All with men 2A in one family?

Lazar Diana-Georgiana , Vasilescu Sorana L. , Elena Oros Sabina , Dumitrascu Anda , Smarandache Romeo , Caragheorgheopol Andra

Multiple endocrine neoplasya type 2 (MEN-2) is a rare hereditary complex disorder caused by a germline activating mutation of the RET proto-oncogene. The estimated prevalence is approximately 1:30.000. Three clinical forms have been described depending on the phenotype: MEN2A (80%), MEN2B and familial medullary thyroid carcinoma (MTC).Clinically, MEN2A present with MTC (80–100%), unilateral or bilateral pheocromocytoma (40%) and primary hyperparath...